Case of Streptococcus massiliensis isolation from blood of patient with meningoencephalitis
https://doi.org/10.47183/mes.2022.030
Abstract
To date, Streptococcus мassiliensis, the representative of human oral normobiota, was detected in the patients' blood only twice (which was confirmed by the reports published in 2004 and 2015). The patient with the demyelinating disease of the nervous system was routinely admitted to the neurological department for further examination and treatment. The diagnosis of meningoencephalitis was established based on the laboratory and instrumental tests. Meningoencephalitis was later complicated by bilateral multilobar pneumonia, systemic inflammatory response syndrome, and multisystem organ failure. After sharp deterioration of patient's health in the form of the decreased level of consciousness and brainstem symptoms, cerebrospinal fluid was tested by PCR for markers of viral and bacterial infections, and blood was cultured. Bacterial growth was detected in blood culture, and then Streptococcus massiliensis, susceptible to benzylpenicillin, vancomycin, levofloxacin, linezolid, sulfamethoxazole/trimethoprim, and erythromycin, was identified by time-of-flight mass spectrometry. Thus, it seems necessary to focus attention on this case of the Str. massiliensis isolation from blood due to the near total lack of data on the Str. мassiliensis biological role and the more frequent isolation of bacteria of the genus Streptococcus from sterile human body fluids.
About the Authors
O. V. LyangRussian Federation
Olga V. Lyang
Ostrovitianov, 1, str. 10, 117997, Moscow
A. V. Pakhilova-Popova
Russian Federation
Moscow
A. R. Kabaeva
Russian Federation
Moscow
O. V. Boyko
Russian Federation
Moscow
N. A. Shamalov
Russian Federation
Moscow
References
1. Chebotar IV, Polikarpova SV, Bocharova YuA, Mayanskij NA. Ispol'zovanie vremyaproletnoj mass-spektrometrii s matrichno- aktivirovannoj lazernoj desorbciej/ionizaciej (MALDI-TOF MS) dlya identifikacii bakterial'nyx i gribkovyx vozbuditelej III–IV grupp patogennosti. Laboratornaya sluzhba. 2018; 7 (2): 78–86. Russian.
2. Bush LM, Vazquez-Pertejo MT. MSD Manual for the Professional. Streptococcal Infections. 2021. Available from: https://www.msdmanuals.com/professional/infectious-diseases/gram-positive-cocci/streptococcal-infections.
3. Glazunova OO, Raoult D, Roux V. Streptococcus massiliensis sp. nov., isolated from a patient blood culture. Int J Syst Evol Microbiol. 2006; 56 (Pt 5): 1127–31.
4. Póntigo F, Silva C, Moraga M, Flores SV. Streptococcus massiliensis in the human mouth: a phylogenetic approach for the inference of bacterial habitats Genetics and Molecular Research. 2015; 14 (4): 19184–90.
5. Alieva EV, Kaftyreva LA, Makarova MA, Tartakovskij IS. Prakticheskie rekomendacii po preanaliticheskomu ehtapu mikrobiologicheskix issledovanij. Chast' I. Bakteriologicheskie issledovaniya. Laboratornaya sluzhba. 2020; 9 (2): 45–66. Russian.
6. Hachiya Y, Miyata R, Tanuma N, Hongou K, Tanaka K, Shimoda K, et al. Autoimmune neurological disorders associated with group-A beta-hemolytic streptococcal infection. Brain Dev. 2013; 35 (7): 670–4. DOI: 10.1016/j.braindev.2012.10.003. Epub 2012 Nov 9. PMID: 23142103.
7. Madathil S, Matsumoto S, Mathews KD, Glykys J. Central Nervous System Infections Due to Streptococcus anginosus Group: A Single-Center Case Series. J Child Neurol. 2022; 37 (3): 210–7. DOI: 10.1177/08830738211052132. Epub 2021 Dec 1. PMID: 34851209.
8. Bhatia NS, Farrell JJ, Sampath R, Ranken R, Rounds MA, Ecker DJ, et al. Identification of Streptococcus intermedius central nervous system infection by use of PCR and electrospray ionization mass spectrometry. J Clin Microbiol. 2012; 50 (12): 4160–2. DOI: 10.1128/JCM.01296-12. Epub 2012 Oct 3. PMID: 23035188; PMCID: PMC3502992.
Review
For citations:
Lyang O.V., Pakhilova-Popova A.V., Kabaeva A.R., Boyko O.V., Shamalov N.A. Case of Streptococcus massiliensis isolation from blood of patient with meningoencephalitis. Extreme Medicine. 2022;24(3):70-73. https://doi.org/10.47183/mes.2022.030